Article Text

Download PDFPDF

Role of itraconazole in haematology/oncology
  1. N A Pandya1,
  2. A A Atra1,
  3. U Riley2,
  4. C R Pinkerton1
  1. 1Department of Paediatric Oncology, The Royal Marsden Hospital NHS Trust, Institute of Cancer Research, Sutton, Surrey SM2 5PT, UK
  2. 2Department of Microbiology, The Royal Marsden Hospital NHS Trust
  1. Correspondence to:
    Professor C R Pinkerton, Institute of Cancer Research, The Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, UK;


The antifungal agents most frequently used in prophylaxis and treatment are amphotericin B (and its new lipid forms) and azoles such as fluconazole, itraconazole, and more recently voriconazole. This review assesses the role of itraconazole in paediatric haematology/oncology practice. Its broader spectrum of activity and availability in oral and intravenous forms allow a flexible approach in the management of fungal infections.

  • itraconazole
  • invasive fungal infections
  • prophylaxis
  • GVHD, graft versus host disease
  • IFI, invasive fungal infections
View Full Text

Statistics from


    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.